Study of CART BP Pro Wearable Device for Blood Pressure Control Compared to Usual Care in Adults with Uncontrolled Hypertension in Korea

What this Trial Is About

Researchers are evaluating the use of CART BP Pro, a wearable cuffless blood pressure monitoring device, to guide blood pressure management in Korean adults with uncontrolled hypertension. This device uses photoplethysmography technology to provide continuous ambulatory blood pressure monitoring. The study compares this method to usual care based on office blood pressure measurements, aiming to assess whether CART BP Pro-guided treatment improves blood pressure control and safety. Participants with uncontrolled hypertension despite ongoing antihypertensive therapy will be randomly assigned to either a group managed using CART BP Pro data or a usual care group following conventional office measurements. Both groups will receive antihypertensive medications according to clinical guidelines, including drugs like angiotensin receptor blockers, calcium channel blockers, and thiazide diuretics. The study period includes 24 weeks of follow-up, with an optional extension to 48 weeks for further observation. During the trial, participants will have their blood pressure monitored continuously with the CART BP Pro device or measured in the office. Researchers will assess blood pressure control using 24-hour ambulatory blood pressure monitoring at 24 weeks and track safety by recording any treatment-emergent adverse events. Additional measures include blood pressure load, achievement of target blood pressure, daytime and nighttime blood pressure averages, and changes in office blood pressure. The study takes place at multiple centers and monitors participants closely for efficacy and safety outcomes.

CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension